Post-marketing PV in China

Post-marketing PV in China Definition Post-marketing pharmacovigilance (PV) refers to the collection, monitoring, assessment, and reporting of adverse drug reactions (ADRs) that occur after a drug has been approved and marketed for use in the general population. Post-marketing PV activities are carried out by regulatory authorities, pharmaceutical companies, and healthcare professionals to ensure that drugs remain safe for use in the general population. The ultimate goal of post-marketing PV is to identify and minimize the risks associated with the use of medicinal products, thereby ensuring the safety and well-being of patients. ADR Monitoring Network in China and Main Responsible Competent Authority China’s drug adverse reaction monitoring network is divided into four levels, including the National Centre for Drug Re-evaluation (CDR),

Read More »

Recent News